NCT06328062 Comparing Efficiency of Mirogabalin and Pregabalin in Primary TKA
| NCT ID | NCT06328062 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Thammasat University Hospital |
| Condition | Pain Postoperative |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2024-04-01 |
| Primary Completion | 2025-05-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2024-04-01 with a primary completion date of 2025-05-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this RCT is to compare efficacy between mirogabalin and pregabalin in pain reducing after unilateral primary total knee arthroplasty. The main question\[s\] it aims to answer are: • Does mirogabalin have better pain reduction than pregabalin after unilateral primary total knee arthroplasty. Participants will randomized to mirogabalin or pregabalin group and will take the drug for 6 weeks after TKA. Researchers will compare to pregabalin group to see pain and functional outcomes after TKA.
Eligibility Criteria
Inclusion Criteria: 1. Age 50-85 years old 2. Unilateral primary osteoarthritis undergoing primary TKA 3. ASA I-III Exclusion Criteria: 1. GFR \<60 2. Allergy to drug in this study 3. Cannot underwent spinal anesthesia and adductor canal block 4. Taking gabapentinoid within 3 months before surgery 5. History of previous knee surgery 6. Severe liver disease
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06328062 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, up to 85 Years, studying Pain Postoperative. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06328062 currently recruiting?
Yes, NCT06328062 is actively recruiting participants. Contact the research team at y.tanariyakul@gmail.com for enrollment information.
Where is the NCT06328062 trial being conducted?
This trial is being conducted at Khlong Luang, Thailand.
Who is sponsoring the NCT06328062 clinical trial?
NCT06328062 is sponsored by Thammasat University Hospital. The trial plans to enroll 80 participants.